NYSE - Delayed Quote USD

Medifast, Inc. (MED)

Compare
18.30 -0.30 (-1.61%)
At close: August 30 at 4:00 PM EDT
18.50 +0.20 (+1.09%)
After hours: August 30 at 6:44 PM EDT
Loading Chart for MED
DELL
  • Previous Close 18.60
  • Open 18.64
  • Bid 18.00 x 800
  • Ask 18.95 x 1000
  • Day's Range 18.07 - 18.99
  • 52 Week Range 17.86 - 83.63
  • Volume 229,828
  • Avg. Volume 499,039
  • Market Cap (intraday) 200.154M
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) 6.83
  • EPS (TTM) 2.68
  • Earnings Date Nov 4, 2024 - Nov 8, 2024
  • Forward Dividend & Yield 6.60 (36.07%)
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est 17.25

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

medifastinc.com

634

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MED

View More

Performance Overview: MED

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MED
72.78%
S&P 500
18.42%

1-Year Return

MED
78.02%
S&P 500
25.59%

3-Year Return

MED
91.13%
S&P 500
25.26%

5-Year Return

MED
77.69%
S&P 500
93.14%

Compare To: MED

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MED

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    200.15M

  • Enterprise Value

    55.75M

  • Trailing P/E

    6.83

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.26

  • Price/Book (mrq)

    0.98

  • Enterprise Value/Revenue

    0.07

  • Enterprise Value/EBITDA

    1.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.81%

  • Return on Assets (ttm)

    6.99%

  • Return on Equity (ttm)

    15.01%

  • Revenue (ttm)

    770.18M

  • Net Income Avi to Common (ttm)

    29.33M

  • Diluted EPS (ttm)

    2.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    163.5M

  • Total Debt/Equity (mrq)

    9.30%

  • Levered Free Cash Flow (ttm)

    18.05M

Research Analysis: MED

View More

Company Insights: MED

Research Reports: MED

View More

People Also Watch